3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Mesothelioma
2
Solid Tumors
1
Solid Tumor, Adult
1
Solid Tumor
1
Retinoblastoma
1
Pseudomyxoma Peritonei
1
Mesothelioma, Malignant
1
Lung Diseases
1
Hematopoietic and Lymphatic System Neoplasm
1
Colonic Neoplasms
1
Childhood Solid Tumor
1
Carcinoma, Ovarian Epithelial
1
Appendiceal Neoplasms
1
Advanced Cancers
1
Advanced Cancer
1
Interventions
pembrolizumab
7
Radiotherapy
3
Proton Therapy
3
Interleukin-2
3
Cyclophosphamide
3
spartalizumab
2
fludarabine
2
Rosuvastatin Calcium
2
Paclitaxel
2
Ipilimumab
2
Immune Checkpoint Inhibitors
2
Cetuximab
2
Carboplatin
2
Blood Specimen Collection
2
toripalimab
1
tislelizumab
1
sotorasib
1
peposertib
1
pazopanib
1
patritumab deruxtecan
1
palbociclib
1
osimertinib
1
niraparib
1
neotil
1
necitumumab
1
mirdametinib
1
leronlimab
1
lenvatinib
1
atezolizumab
1
apatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Solid Tumor, Adult
×
Surveys and Questionnaires
×
Other solid neoplasm
×
Clear all
NCT04310033
2021-09-01
QdV-ONCOREA
University Hospital, Grenoble
Completed
60 enrolled